FIBROGEN, INC.

FGEN

Delayed - 11/24 04:00:00 pm
41.33USD	+2.84%

Prev.	40.1900
Open	40.3900
High	42.0600
Low	40.0000
Volume	878 085

11/12	FIBROGEN INC : Entry into a Material Definitive Agreement (form 8-K)
11/09	FibroGen : to Present at Upcoming Investor Conferences
11/06	FibroGen : to Present at Upcoming Investor Conferences
11/06	FibroGen to Present at Upcoming Investor Conferences

	Short Term	Mid-Term	Long Term
Trend	Neutral	Neutral	Bullish
Resistance	45,6	49,0	48,8
Spread/Res.	-9,4%	-16%	-15%
Spread/Supp.	7,7%	27%	18%
Support	38,4	32,6	35,0

Sales 2020	231 M - -
Net income 2020	-147 M - -
Net Debt 2020	- - -
P/E ratio 2020	-25,4x
Yield 2020	-

Capitalization	3 658 M 3 658 M -
Capi. / Sales 2020	15,8x
Capi. / Sales 2021	7,45x
Nbr of Employees	531
Free-Float	91,7%

FibroGen, Inc. is a biopharmaceutical company discovering and developing a pipeline of first- in-class therapeutics. The Company applies its proficiency in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance medicines for the treatment of anemia, fibrotic...

>> Read more

Sector :

Biotechnology & Medical Research - NEC

Calendar :

2021-03-03 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	OUTPERFORM
Number of Analysts	9
Average target price	62,13 $
Last Close Price	40,19 $
Spread / Highest target	129%
Spread / Average Target	54,6%
Spread / Lowest Target	9,48%